Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by Pizzedon Feb 07, 2013 7:49am
133 Views
Post# 20950678

RE: Financial Expenses 2Q

RE: Financial Expenses 2Q

I'm not 100% certain what the exact costs associated with the Royalty Capital loan is, but it is quite clear that it is costing them money, a very scarce commodity for BNC.

 

From September 27, 2012 Year End Report:

 

 

"The Company has estimated the future cash flows of interest, principal and royalty interest associated
with this loan facility and recorded the loan at its effective interest rate of 24%."
Bullboard Posts